Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.
Search inside this report
Single User License
Departmental Site License (one location, 10 users)